# LANREOTIDE ACETATE
> **ANDA217193** · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2024-05-21
## Drug
- **FDA Application Number:** ANDA217193
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LANREOTIDE ACETATE
- **Generic name:** LANREOTIDE ACETATE
- **Active ingredients:** LANREOTIDE ACETATE
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** INVAGEN PHARMS
- **Manufacturer:** Cipla USA Inc.
- **First approval:** 2024-05-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217193)
---
*MORVS · CC0 1.0*